Including Both Costs and Effects – The Challenge of Using Cost-Effectiveness Data in National-Level Policy-Making: A Response to Recent Commentaries

Document Type : Correspondence


1 Division of Health Care Analysis, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

2 Department of Cardiology and Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden


Main Subjects

Incorporating cost-effectiveness data in the priority-setting decisions is a distinguishing feature in the Swedish national guidelines. This differentiates the Swedish guidelines from its European and American counterparts. The broader perspective is aimed at facilitating explicit resource allocations and priority-setting in healthcare, all in accordance with the three guiding ethical principles stated in the Health and Medical Services Act.1... (Read more...)

  1. Health and Medical Service Act, SFS 1982:763 (1982).
  2. Eckard N, Janzon M, Levin LA. Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden. Int J Health Policy Manag. 2014;3(6):323-332.       doi:10.15171/ijhpm.2014.105
  3. Williams I, Bryan S. Lonely at the top and stuck in the middle? The ongoing challenge of using cost-effectiveness information in priority setting. Int J Health Policy Manag. 2014;4(3):185-187. doi:10.15171/ijhpm.2015.32
  4. Erntoft S. The use (or rather non-use) of cost-effectiveness data in priority setting decisions – are we underestimating the barriers to using health economics in real world priority setting decisions? Int J Health Policy Manag. 2015;4(3):181-183. doi:10.15171/ijhpm.2015.28
  5. Williams I. Institutions, cost-effectiveness analysis and health care rationing: the example of health care coverage in the English National Health Service. Policy Polit.2013;41(2):223-239. doi:10.1332/030557312x655477
  6. Nedlund AC, Garpenby P. Puzzling about problems: the ambiguous search for an evidence-based strategy for handling influx of health technology. Policy Sci. 2014;47(4):367-386. Doi:10.1007/s11077-014-9198-1
  7. Ernoft S. The Use of Health Economic Evaluations in Pharmaceutical Priority Setting. The Case of Sweden [dissertation]. Lund: Lund Business Press, Lund Institute of Economic Research, Lund University; 2010
  8. Youngkong S. Incorporating cost-effectiveness data in a fair process for priority setting efforts. Int J Health Policy Manag. 2015;4(7):483-485. doi:10.15171/ijhpm.2015.81